The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods ...

While countless long COVID sufferers put Pretorius’s theory to the test, her new focus is raising its awareness. Not only ...